Issue: February 2016
February 23, 2016
1 min read
Save

Case Challenges in Pediatric Fatty Liver: What to Look For and When to Refer

Issue: February 2016
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Non-alcoholic fatty liver disease (NAFLD) is characterized by excess fat deposition in the liver due to causes other than alcohol consumption and tends to develop in individuals who are overweight, obese or have diabetes, hypercholesterolemia or hypertriglyceridemia. With the growing obesity epidemic, pediatric NAFLD is on the rise. Left unmanaged, NAFLD may progress to cause progressive fibrosis and cirrhosis. Children with NAFLD may not present with symptoms or elevated liver function tests, and may often be misdiagnosed with mimics of the disease. In this activity, a discussion between a leading hepatologist and pediatrician will elucidate the pathogenesis, risk factors, screening recommendations, differential diagnostic strategies, management, and prevention of pediatric NAFLD using a case-based approach.

Click here to see this Education Lab Activity.

Learning Objectives:

Upon successful completion of this educational activity, participants should be better able to:

  • Recognize the etiologies of fatty liver in children and adolescents, and the importance of appropriate screening and referral.
  • Examine criteria and methodologies used to differentially diagnose and treat fatty liver in children and adolescents to improve patient health.

Overview

Author(s)/Faculty: Ruba Azzam, MD; James W. Mitchell, MD, FAAP
Source: Healio Infectious Diseases in Children Education Lab
Type: Multimedia
Articles/Items: 3
Release Date: 5/28/2015
Expiration Date: 5/27/2016
Credit Type: CME
Number of Credits: 0.5
Cost: Free
Provider: Vindico Medical Education

CME Information

Provider Statement: This continuing medical education activity is provided by Vindico Medical Education.
Support Statement: This activity is supported by an educational grant from Synageva BioPharma Corp.
Target Audience: The intended audience for the activity is pediatricians, hepatologists and other health care professionals responsible for the identification, evaluation, and treatment of pediatric lipid and liver abnormalities.